Screening for brain metastases in patients with stage III non-small-cell lung cancer, magnetic resonance imaging or computed tomography? A prospective study

Janna Schoenmaekers, Paul Hofman, Gerben Bootsma, Marcel Westenend, Machiel de Booij, Wendy Schreurs, Ruud Houben, Dirk De Ruysscher, Anne-Marie Dingemans, Lizza E. L. Hendriks*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)88-96
Number of pages9
JournalEuropean Journal of Cancer
Volume115
DOIs
Publication statusPublished - Jul 2019

Keywords

  • NSCLC
  • Screening
  • Brain metastases
  • Magnetic resonance imaging
  • Computed tomography
  • CEREBRAL METASTASES
  • PHASE-III
  • FDG-PET
  • DIAGNOSIS
  • CHEMOTHERAPY
  • CT
  • CHEMORADIOTHERAPY
  • CHEMORADIATION
  • PROGNOSIS
  • ACCURACY

Cite this